Shelter Pharma Stock Screener | Share Price & Fundamental Analysis
SHELTER
Pharmaceuticals
Track Shelter Pharma share price live with TickJournal's free stock screener.
Analyze Shelter Pharma share price history trends and compare 52-week high low
levels.
Calculate SHELTER stock fair value using fundamental analysis and view live share price charts.
Determine Shelter Pharma share intrinsic value and compare it with current SHELTER share price.
Record your Shelter Pharma trades in TickJournal's free trading journal and track your portfolio performance.
Shelter Pharma Market Cap
₹60.01 Cr.
EPS (TTM)
₹6.26
Dividend Yield
-
Debt to Equity
0.02
Shelter Pharma 52 Week Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹48.00
Total Equity
₹43.00
Shelter Pharma Share Price History - Stock Screener Chart
Screen SHELTER historical share price movements with interactive charts. Analyze price trends and patterns.
Shelter Pharma Company Profile - Fundamental Screener
Screen Shelter Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHELTER shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE013V01011
Shelter Pharma Balance Sheet Screener
Screen SHELTER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Assets | 33 | 30 | 19 | 10 | 8 | 8 |
| Fixed Assets | 6 | 4 | 2 | 2 | 2 | 2 |
| Liabilities | ||||||
| Total Liabilities | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Liabilities | 1 | 1 | 1 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 43 | 36 | 15 | 9 | 7 | 7 |
| Share Capital | 12 | 12 | 8 | 1 | 1 | 1 |
| Reserves & Surplus | 31 | 24 | 7 | 8 | 7 | 7 |
Shelter Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Shelter Pharma income statement and profit fundamentals.
Analyze SHELTER quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shelter Pharma share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 51 | 40 | 36 | 30 | 23 | 30 |
| Expenses | 0 | 41 | 32 | 28 | 27 | 22 | 30 |
| EBITDA | 0 | 10 | 9 | 8 | 3 | 0 | 0 |
| Operating Profit % | 0.00% | 20.00% | 21.00% | 22.00% | 10.00% | 1.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 10 | 8 | 7 | 3 | 0 | 0 |
| Tax | 0 | 2 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 7 | 6 | 5 | 2 | 0 | 0 |
| EPS | 0.00 | 6.26 | 5.36 | 6.72 | 42.54 | 0.88 | 1.77 |
Shelter Pharma Cash Flow Screener - Liquidity Fundamentals
Screen SHELTER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2017-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 6 | -2 | 0 | 1 | 0 | 0 | 0 |
| Investing Activities | -7 | -4 | 0 | -1 | 0 | 0 | 0 |
| Financing Activities | 0 | 11 | 0 | 0 | 1 | 0 | 0 |
| Net Cash Flow | -2 | 5 | 0 | 0 | 0 | 0 | 0 |
Shelter Pharma Shareholding Pattern Screener
See Shelter Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Shelter Pharma promoter holding and ownership changes for SHELTER on TickJournal.
| Item | 2025-Mar | 2025-Aug | 2025-Sept | 2025-Oct | 2025-Nov | 2024-Mar | 2024-Sept | 2023-Aug |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.32% | 52.32% | 52.32% | 46.91% | 47.19% | 56.89% | 54.97% | 56.89% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.24% | 42.69% | 42.82% | 49.25% | 49.32% | 30.23% | 40.12% | 29.22% |
| Other Holding | 4.44% | 4.99% | 4.86% | 3.84% | 3.49% | 12.88% | 4.91% | 13.89% |
| Shareholder Count | 1,119 | 1,153 | 1,109 | 1,094 | 1,094 | 836 | 868 | 0 |
Shelter Pharma Share Dividend Screener - Share Yield Analysis
Check Shelter Pharma dividend history with payout and yield data.
View Shelter Pharma dividend details including ex-dates and amounts for SHELTER stock.
Shelter Pharma Stock Index Membership
See which indices include Shelter Pharma stock.
Check SHELTER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shelter Pharma Market Events Screener - Corporate Actions
Get Shelter Pharma corporate actions including splits, bonuses, and buybacks.
Check Shelter Pharma stock events that may affect SHELTER share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.35 /share | -3.84% | ||
| Annual General Meeting | NA | 1.13% | ||
| Dividend | ₹ 0.33 /share | 2.64% | ||
| Annual General Meeting | NA | -2.22% | ||
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.87% |
| 2025-07-23 | 2025-07-23 | Extraordinary General Meeting | NA | 11.04% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 3.95% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 0.58% |
Shelter Pharma Competitors Screener - Peer Comparison
Screen SHELTER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Shelter Pharma Company Announcements - News Screener
Screen SHELTER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2026-03-01 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-12 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-11-17 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday November 17 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only) | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-15 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 15 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only) | View |
| 2025-11-11 | Intimation With Regards To Shelter Pharma Received ISO 22000:2018 Certification | View |
| 2025-11-10 | Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-10 | Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-10 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-05 | Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On 10Th November 2025 | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-10-16 | Board Meeting Outcome for 861000 Equity Shares Allotted Pursuant To Conversion Of Warrants | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-03 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-10-03 | Board Meeting Outcome for 1128000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants. | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |